Transcript Slide 1
NDTMS data on club drugs and NPS
•
Historically, the NDTMS Core Data Set has added individual substances to the list of
available drug codes with each refresh
•
Mephedrone was added to the CDS in 2010/11, so we now have three years’ worth of
data, as well as data on more established club drugs (ecstasy, ketamine etc.)
•
For 2013/14, we have added a series of new codes which describe NPS by their
effects rather than naming individual substances:
8800 NPS Other – predominantly stimulant
8801 NPS Other – predominantly hallucinogenic
8802 NPS Other – predominantly dissociative
8803 NPS Other – predominantly sedative or opioid
8804 NPS Other – predominantly cannabis
8805 NPS Other – effects different to available classifications or not stated
1
Treatment data on club drugs and NPS
NTA published a report on trends in club
drug use in November 2012
• Definition of ‘club drug user’ in this report was any person in treatment since
2005/06 citing any of the following substances:
Ecstasy
Ketamine
GHB/GBL
Methamphetamine
Mephedrone (since introduction to CDS in 2010/11)
• Estimated one million people in England and Wales used one or more of the
above in 2011/12 (CSEW)
• 4,500 over-18s and 2,000 under-18s in treatment for club drugs in 2011/12
• 4% of all new over-18s and 10% of all new under-18s in 2011/12
2
NDTMS data on club drugs and NPS
NTA published a report on trends in club
drug use in November 2012
•
General increasing trend, driven by increasing ketamine presentations and
introduction of mephedrone. Ecstasy presentations have declined since 2005/06, but
are starting to flatline
2500
2000
1500
1000
500
0
05/06
GHB/GBL
3
NDTMS data on club drugs and NPS
06/07
Ketamine
07/08
08/09
Ecstasy
09/10
Methamphetamine
10/11
11/12
Mephedrone
NTA published a report on trends in club
drug use in November 2012
• Relatively likely to leave treatment successfully and completion rates are
improving over time
70%
60%
54%
61%
53%
47%
50%
42%
40%
30%
58%
33%
28%
41%
43%
38%
31%
25%
21%
20%
10%
0%
05/06
06/07
07/08
Any club drug cited
08/09
09/10
10/11
11/12
All clients exiting treatment
• ‘Tend to be a group whose level of functioning is quite high’
4
NDTMS data on club drugs and NPS
Treatment data on club drugs/NPS and
injecting
• Club drugs report highlighted that rates of injecting among club drug users
increased from 6% to 8%, bucking the general decreasing injecting trend
• Can be difficult to determine definitively from NDTMS data if people are
injecting these drugs, particularly where reported adjunctively to heroin
• However, particularly high rates observed among methamphetamine users
(22%) and GHB users (11%), even where these were the only reported
substances
• Up to this point, relatively low rates of injecting reported among clients in
treatment for mephedrone (5%) – although much higher where heroin use
also indicated
5
NDTMS data on club drugs and NPS